GT
39
-3
ORCL
37
4
CHD
35
-5
MNST
59
3
HBAN
87
5
OI
58
11
AME
75
3
GD
64
2
MDLZ
26
-2
WM
60
3
CL
62
4
CME
52
7
FFIV
51
4
TEL
69
3
UA
36
3
PEG
50
4
PPL
57
2
FLS
63
2
MCHP
58
11
LMT
62
3
GT
39
-3
ORCL
37
4
CHD
35
-5
MNST
59
3
HBAN
87
5
OI
58
11
AME
75
3
GD
64
2
MDLZ
26
-2
WM
60
3
CL
62
4
CME
52
7
FFIV
51
4
TEL
69
3
UA
36
3
PEG
50
4
PPL
57
2
FLS
63
2
MCHP
58
11
LMT
62
3
Financhill
Back

Credit Suisse Asset Management Income Fund Inc. Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Sell
39

CIK
Credit Suisse Asset Management Income Fund Inc.

Last Price:
$2.82
Seasonality Move:
2.58%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$31.98
Seasonality Move:
-10.99%
Sell
39
Credit Suisse Asset Management Income Fund Inc. (CIK) is a Sell

Is Credit Suisse Asset Management Income Fund Inc. a Buy, Sell or Hold?

  • The current Credit Suisse Asset Management Income Fund Inc. [CIK] share price is $2.81. The Score for CIK is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • CIK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CIK Stock Price Chart

What is Credit Suisse Asset Management Income Fund Inc.'s stock price today?

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

CIK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 47.14 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.79 - 2.83) Sell
Bollinger Bands (100): (2.82 - 2.98) Sell

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

CIK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.81 Buy
20-day SMA: 2.82 Sell
50-day SMA: 2.83 Sell
200-day SMA: 2.89 Sell
8-day EMA: 2.81 Sell
20-day EMA: 2.82 Sell
50-day EMA: 2.84 Sell
200-day EMA: 2.9 Sell

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

Credit Suisse Asset Management Income Fund Inc. Earnings Growth & CIK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

Credit Suisse Asset Management Income Fund Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):